Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 6;21(23):9298.
doi: 10.3390/ijms21239298.

The Roles of Sodium-Independent Inorganic Phosphate Transporters in Inorganic Phosphate Homeostasis and in Cancer and Other Diseases

Affiliations
Review

The Roles of Sodium-Independent Inorganic Phosphate Transporters in Inorganic Phosphate Homeostasis and in Cancer and Other Diseases

Marco Antonio Lacerda-Abreu et al. Int J Mol Sci. .

Abstract

Inorganic phosphate (Pi) is an essential nutrient for the maintenance of cells. In healthy mammals, extracellular Pi is maintained within a narrow concentration range of 0.70 to 1.55 mM. Mammalian cells depend on Na+/Pi cotransporters for Pi absorption, which have been well studied. However, a new type of sodium-independent Pi transporter has been identified. This transporter assists in the absorption of Pi by intestinal cells and renal proximal tubule cells and in the reabsorption of Pi by osteoclasts and capillaries of the blood-brain barrier (BBB). Hyperphosphatemia is a risk factor for mineral deposition, the development of diseases such as osteoarthritis, and vascular calcifications (VCs). Na+-independent Pi transporters have been identified and biochemically characterized in vascular smooth muscle cells (VSMCs), chondrocytes, and matrix vesicles, and their involvement in mineral deposition in the extracellular microenvironment has been suggested. According to the growth rate hypothesis, cancer cells require more phosphate than healthy cells due to their rapid growth rates. Recently, it was demonstrated that breast cancer cells (MDA-MB-231) respond to high Pi concentration (2 mM) by decreasing Na+-dependent Pi transport activity concomitant with an increase in Na+-independent (H+-dependent) Pi transport. This Pi H+-dependent transport has a fundamental role in the proliferation and migratory capacity of MDA-MB-231 cells. The purpose of this review is to discuss experimental findings regarding Na+-independent inorganic phosphate transporters and summarize their roles in Pi homeostasis, cancers and other diseases, such as osteoarthritis, and in processes such as VC.

Keywords: cancer; inorganic phosphate; inorganic phosphate homeostasis; sodium-independent Pi transport.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the roles of sodium-independent Pi transport in Pi homeostasis. Na+-independent Pi transport facilitates the absorption of Pi in intestinal cells [9,19] and proximal tubule cells [10] and the reabsorption of Pi in bone by osteoclast-like cells derived from RAW264.7 cells (H+-dependent Pi transport) [11] and in capillaries of the blood–brain barrier (BBB) (anion exchange) [14].
Figure 2
Figure 2
Schematic of the role of sodium-independent Pi transport in the development of breast cancer. Na+-independent Pi transport and Na+-dependent Pi transport in breast cancer cells promote cell adhesion and migration, which are important for maintaining cancer metastasis [15,42].
Figure 3
Figure 3
Schematic of the role of sodium-independent Pi transport in the development of vascular calcification (VC). Na+-independent and Na+-dependent Pi transport (PiT-1 and PiT-2) in vascular smooth muscle cells (VSMCs) contributes to hydroxyapatite deposition in these cells [13,51].
Figure 4
Figure 4
Schematic of the role of sodium-independent Pi transport in the development of osteoarthritis. Na+-independent and Na+-dependent Pi transport (PiT-1 and PiT-2) and annexins (Ca2+ channels) in chondrocytes or matrix vesicles promote cartilage mineralization and consequently osteoarthritis [12,20].

References

    1. Sapio L., Naviglio S. Inorganic phosphate in the development and treatment of cancer: A Janus Bifrons? World J. Clin. Oncol. 2015;6:198–201. doi: 10.5306/wjco.v6.i6.198. - DOI - PMC - PubMed
    1. Takeda E., Taketani Y., Morita K., Tatsumi S., Katai K., Nii T., Yamamoto H., Miyamoto K.-I. Molecular mechanisms of mammalian inorganic phosphate homeostasis. Adv. Enzym. Regul. 2000;40:285–302. doi: 10.1016/S0065-2571(99)00036-9. - DOI - PubMed
    1. Iheagwara O.S., Ing T.S., Kjellstrand C.M., Lew S.Q. Phosphorus, phosphorous, and phosphate. Hemodial. Int. 2012;17:479–482. doi: 10.1111/hdi.12010. - DOI - PubMed
    1. Forster I.C., Hernando N., Biber J., Murer H. Phosphate transporters of the SLC20 and SLC34 families. Mol. Asp. Med. 2013;34:386–395. doi: 10.1016/j.mam.2012.07.007. - DOI - PubMed
    1. Levi M., Gratton E., Forster I.C., Hernando N., Wagner C.A., Biber J., Sorribas V., Murer H. Mechanisms of phosphate transport. Nat. Rev. Nephrol. 2019;15:482–500. doi: 10.1038/s41581-019-0159-y. - DOI - PubMed